Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3250)
All Articles published online
|
Mar 27, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bota S, Sporea I, Şirli R, Popescu A, Neghină AM, Dănilă M, Străin M. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review. World J Hepatol 2013; 5(3): 120-126 [PMID: 23556044 DOI: 10.4254/wjh.v5.i3.120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i3/120.htm |
| Number | Citing Articles |
| 1 |
R. Tauste, F. Moreno-Navarro, R. Gallego, M. C. Rubio-Gámez. Analysis of the sensitivity of the impact resonance frequency test as a tool to determine the elastic properties of bituminous materials. Materiales de Construcción 2017; 7(080): 131 doi: 10.3989/mc.2017.04916
|
| 2 |
Kei Morio, Michio Imamura, Yoshiiku Kawakami, Reona Morio, Tomoki Kobayashi, Satoe Yokoyama, Yuko Nagaoki, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Grace Naswa Makokha, C Nelson Hayes, Hiroshi Aikata, Daiki Miki, Hidenori Ochi, Yoji Honda, Nami Mori, Shintaro Takaki, Keiji Tsuji, Kazuaki Chayama. Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients. Journal of Gastroenterology and Hepatology 2017; 32(3): 645 doi: 10.1111/jgh.13511
|
| 3 |
Hélène Fontaine, Marianne Maynard, Cécile Bouix, Maria Patrizia Carrieri, Danielle Botta-Fridlund, Louis D’Alteroche, Filomena Conti, Georges-Philippe Pageaux, Vincent Leroy, Sophie Métivier, Rodolphe Anty, François Durand, Valérie Canva, Antoine Vilotitch, Pascal Lebray, Laurent Alric, Christophe Duvoux, Ventzislava Petrov-Sanchez, Frédérik Beaulieux, Célia Wellems, Christelle Paul, Anne-Marie Roque-Afonso, Bruno Roche, Pierre Pradat, Didier Samuel, Jean-Charles Duclos-Vallée, François Bailly, Sébastien Dharancy, Jean-Didier Grangé, Amir Guidoum, Christophe Hezode, Lawrence Serfaty, Si-Nafa Si-Ahmed, Michelle Sizorn, Anne-Marie Taburet, Elina Teicher. Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT). Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 56 doi: 10.1016/j.clinre.2016.06.006
|
| 4 |
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Akira Kawashima, Yoshimasa Maeda, Toru Niwa, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masao Ichinose. Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus. Gut and Liver 2016; 10(4): 617 doi: 10.5009/gnl15193
|
| 5 |
C. Weil, D. Mehta, G. Koren, B. Pinsky, J. C. Samp, G. Chodick, V. Shalev. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider. Journal of Viral Hepatitis 2018; 25(2): 144 doi: 10.1111/jvh.12800
|
| 6 |
Yajie Wang, Xiao Tan, Yang Zong, Huipeng Lu, Xinyu Zhang, Xiaoli Xia, Huaichang Sun. Enhancing purification and plasma stability of porcine interferon-α/γ by fusion to elastin-like polypeptide. Veterinary Immunology and Immunopathology 2018; 203: 60 doi: 10.1016/j.vetimm.2018.08.003
|
| 7 |
H. Leleu, M. Blachier, I. Rosa. Cost‐effectiveness of sofosbuvir in the treatment of patients with hepatitis C. Journal of Viral Hepatitis 2015; 22(4): 376 doi: 10.1111/jvh.12311
|
| 8 |
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan. Hepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
|
| 9 |
Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito, Maria Cássia Mendes-Corrêa. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de São Paulo 2017; 59(0) doi: 10.1590/s1678-9946201759067
|
| 10 |
Satoshi Shakado, Shotaro Sakisaka, Takeshi Okanoue, Kazuaki Chayama, Namiki Izumi, Joji Toyoda, Eiji Tanaka, Akio Ido, Tetsuo Takehara, Kentaro Yoshioka, Yoichi Hiasa, Hideyuki Nomura, Masataka Seike, Yoshiyuki Ueno, Hiromitsu Kumada. Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus‐related liver cirrhosis: A multicenter retrospective study in Japan. Hepatology Research 2014; 44(9): 983 doi: 10.1111/hepr.12280
|
| 11 |
Louis S. Matza, Sandhya J. Sapra, John F. Dillon, Anupama Kalsekar, Evan W. Davies, Mary K. Devine, Jessica B. Jordan, Amanda S. Landrian, David H. Feeny. Health state utilities associated with attributes of treatments for hepatitis C. The European Journal of Health Economics 2015; 16(9): 1005 doi: 10.1007/s10198-014-0649-6
|
| 12 |
Jean Bousquet, Rodolphe Bourret, Thierry Camuzat, Philippe Augé, Philippe Domy, Jacques Bringer, Nicolas Best, Olivier Jonquet, Jean-Emmanuel de la Coussaye, Michel Noguès, Jean-Marie Robine, Antoine Avignon, Hubert Blain, Bernard Combe, Gérard Dray, Vincent Dufour, Mireille Fouletier, Nicolas Giraudeau, Didier Hève, Claude Jeandel, Isabelle Laffont, Dominique Larrey, Daniel Laune, Cyril Laurent, Pierre Mares, Chantal Marion, Eric Pastor, Jacques-Yvon Pélissier, Françoise Radier-Pontal, Jacques Reynes, Emilie Royère, Marc Ychou, Anna Bedbrook, Sophie Granier, Frédéric Abecassis, Sylvie Albert, Paule Adnet, Bernard Alomène, Michel Amouyal, Sylvie Arnavieilhe, Trias Asteriou, Vincent Attalin, Pierre Aubas, Christine Azevedo, Mélanie Badin, Karima Bakhti, Gregory Baptista, Benoit Bardy, Marie-Pierre Battesti, Olivier Bénézet, Pierre-Louis Bernard, Claudine Berr, Jacquie Berthe, Xavier Bobia, Joël Bockaert, Catherine Boegner, Sylvie Boichot, Huei-Yune Bonnin, Philippe Boulet, Stéphane Bouly, Chokri Boubakri, Arnaud Bourdin, Jean-Luc Bourrain, Gérard Bourrel, Vincent Bouix, Cyril Breuker, Valérie Bruguière, Jacques Burille, Stéphane Cade, Davide Caimmi, Marie-Virginie Calmels, William Camu, Gérard Canovas, Véronique Carre, Giacomo Cavalli, Guillaume Cayla, Raphaël Chiron, Pierre-Géraud Claret, Pauline Coignard, Flavia-Oana Coroian, David Costa, Pierre Costa, Jérome Cottalorda, Bertrand Coulet, Anne-Laure Coupet, Marie-Christine Courrouy-Michel, Philippe Courtet, Jean-Paul Cristol, Valérie Cros, Frédéric Cuisinier, Claire Daien, Marianna Danko, Philippe Dauenhauer, Michel Dauzat, Miren David, Jean-Marc Davy, Didier Delignières, Pascal Demoly, Matthieu Desplan, Henriette Dhivert-Donnadieu, Pierre Dujol, Arnaud Dupeyron, Gérard Dupeyron, Oude Engberink, Michel Enjalbert, Charles Fattal, Jérôme Fernandes, Pierre Fesler, Philippe Fraisse, Jérôme Froger, Philippe Gabrion, Emilie Galano, Marion Gellerat-Rogier, Anthony Gellis, Arnaud-Yves Goucham, Fares Gouzi, Florence Gressard, Jean-Christophe Gris, Bernard Guillot, David Guiraud, Valérie Handweiler, Olivier Hantkié, Maurice Hayot, Christian Hérisson, Cherif Heroum, Didier Hoa, Sylvain Jacquemin, Samir Jaber, Dominique Jakovenko, Christophe Jorgensen, Laurent Journot, Michel Kaczorek, Pascal Kouyoumdjian, Pierre Labauge, Liliane Landreau, Martine Lapierre, Catherine Leblond, Marie-Suzanne Léglise, Jean-Marc Lemaitre, Vincent Le Moing, Alain Le Quellec, Françoise Leclercq, Sylvain Lehmann, Béatrice Lognos, Jean-Marc Lussert, Alain Makinson, Kevin Mandrick, Vincent Marmelat, Pierre Martin-Gousset, Amélie Matheron, Gwen Mathieu, Marc Meissonnier, Grégoire Mercier, Patrick Messner, Cyril Meunier, Michel Mondain, Raul Punta-Morales, Jacques Morel, David Morquin, Denis Mottet, Philippe Nérin, Pierre Nicolas, Gregory Ninot, Fabrice Nouvel, Jean-Paul Ortiz, Delphine Paccard, Guillaume Pandraud, Marie-Pierre Pasdelou, Jean-Luc Pasquié, Karine Patte, Stéphane Perrey, Yves-Marie Pers, Marie-Christine Picot, Jean-Philippe Pin, Nathalie Pinto, Emilie Porte, Fabienne Portejoie, Jean-Louis Pujol, Xavier Quantin, Isabelle Quéré, Nathalie Raffort, Sofiane Ramdani, Jean Ribstein, Isabelle Rédini-Martinez, Sylvain Richard, Karen Ritchie, Jean-Pierre Riso, François Rivier, Christine Rolland, François Roubille, Denis Sablot, Jean-Luc Savy, Laurent Schifano, Pierre Senesse, Roland Sicard, Baya Soua, Yannick Stephan, Denise Strubel, Ariane Sultan, Roxana Taddei-Ologeanu, Guillaume Tallon, Michel Tanfin, Hervé Tassery, Isabel Tavares, Kjerstin Torre, Jacques Touchon, Vincent Tribout, Alain Uziel, Philippe Van de Perre, Xavier Vasquez, Jean-Michel Verdier, Céline Vergne-Richard, Grégoire Vergotte, Laurence Vian, Christine Viarouge-Reunier, François Vialla, Frédéric Viart, Max Villain, Maxime Villiet, Emilie Viollet, Anne Wojtusciszyn, Martine Aoustin, Christian Bourquin, Jacques Mercier. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon). La Presse Médicale 2015; 44: S6 doi: 10.1016/j.lpm.2015.07.013
|
| 13 |
Suraj A. Sharma, Jordan J. Feld. Management of HCV in Cirrhosis—a Rapidly Evolving Landscape. Current Gastroenterology Reports 2015; 17(5) doi: 10.1007/s11894-015-0443-3
|
| 14 |
Jia‐Horng Kao, Donald M. Jensen, Michael P. Manns, Ira Jacobson, Hiromitsu Kumada, Joji Toyota, Jeong Heo, Boris Yoffe, William Sievert, Fernando Bessone, Cheng‐Yuan Peng, Stuart K. Roberts, Youn‐Jae Lee, Rafia Bhore, Patricia Mendez, Eric Hughes, Stephanie Noviello. Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis. Liver International 2016; 36(7): 954 doi: 10.1111/liv.13049
|
| 15 |
Partha K. Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J. Cohen, Humberto E. Behorquez, Ian Carmody, George Loss, Luis A. Balart, Tong Wu, Srikanta Dash, Ranjit Ray. Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis. PLoS ONE 2014; 9(9): e108616 doi: 10.1371/journal.pone.0108616
|
| 16 |
J. Bousquet, C. Bourquin, P. Augé, P. Domy, J. Bringer, M. Aoustin, T. Camuzat, R. Bourret, N. Best, O. Jonquet, J.E. de la Coussaye, J.M. Robine, A. Avignon, H. Blain, N. Giraudeau, D. Hève, C. Jeandel, I. Laffont, D. Larrey, C. Laurent, M. Noguès, J.Y. Pélissier, F. Radier-Pontal, E. Royère, A. Bedbrook, S. Granier, F. Abecassis, S. Albert, P.A. Adnet, B. Alomène, M. Amouyal, S. Arnavieilhe, V. Attalin, P. Aubas, M. Badin, G. Baptista, B. Bardy, M.P. Battesti, O. Bénézet, P.L. Bernard, C. Berr, J. Berthe, J. Bockaert, C. Boubakri, A. Bourdin, J.L. Bourrain, G. Bourrel, V. Bouix, J. Burille, S. Cade, D. Caimmi, M.V. Calmels, W. Camu, G. Cavalli, G. Cayla, R. Chiron, B. Combe, D.J. Costa, P. Costa, M.C. Courrouy-Michel, P. Courtet, J.P. Cristol, F. Cuisinier, C. Daien, M. Danko, P. Dauenhauer, M. Dauzat, M. David, J.M. Davy, D. Delignières, P. Demoly, H. Dhivert-Donnadieu, G. Dray, P. Dujols, A. Dupeyron, G. Dupeyron, O. Engberink, P. Fesler, M. Gellerat-Rogier, F. Gouzi, F. Gressard, D. Hoa, S. Jacquemin, J.C. Gris, B. Guillot, V. Handweiler, M. Hayot, S. Jaber, D. Jakovenko, C. Jorgensen, L. Journot, M. Kaczorek, M. Lapierre, D. Laune, M.S. Léglise, A. Le Quellec, F. Leclerc, S. Lehmann, B. Lognos, J.M. Lussert, K. Mandrick, V. Marmelat, P. Martin-Gousset, A. Matheron, G. Mathieu, G. Mercier, P. Messner, C. Meunier, M. Mondain, J. Morel, D. Morquin, P. Nérin, G. Ninot, F. Nouvel, J.P. Ortiz, G. Pandraud, M.P. Pasdelou, J.L. Pasquié, E. Pastor, S. Perrey, Y.M. Pers, M.C. Picot, J.P. Pin, N. Pinto, F. Portejoie, J.L. Pujol, X. Quantin, I. Quéré, N. Raffort, S. Ramdani, J. Reynes, J. Ribstein, I. Rédini-Martinez, S. Richard, K. Ritchie, C. Rolland, F. Roubille, E. Roux, A. Salvat, J.L. Savy, Y. Stephan, D. Strubel, A. Sultan, G. Tallon, H. Tassery, K. Torre, A. Uziel, P. Van de Perre, X. Vasquez, J.M. Verdier, G. Vergotte, L. Vian, C. Viarouge-Reunier, F. Vialla, F. Viart, M. Villain, E. Viollet, J. Ankri, G. Berrut, G. Crooks, M.E. Joël, J.P. Michel, B. Samolinski, T. Strandberg, B. Vellas, J. Mercier. MACVIA-LR, Reference site of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon. European Geriatric Medicine 2014; 5(6): 406 doi: 10.1016/j.eurger.2014.07.013
|
| 17 |
|
| 18 |
N.A. Meanwell. Comprehensive Medicinal Chemistry III. 2017; : 553 doi: 10.1016/B978-0-12-409547-2.12406-0
|
| 19 |
Allison Mah, Alissa Wright. Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation. Current Infectious Disease Reports 2016; 18(2) doi: 10.1007/s11908-015-0514-5
|
| 20 |
Vivien A. Sheehan, Alva Weir, Bradford Waters. Hepatitis C and neutropenia. Current Opinion in Hematology 2014; 21(1): 58 doi: 10.1097/MOH.0000000000000006
|
| 21 |
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Ewa Janczewska, Hanna Berak, Andrzej Horban, Marek Sitko, Aleksander Garlicki, Beata Dobracka, Agnieszka Czauż-Andrzejuk, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Włodzimierz Mazur, Zbigniew Deroń, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Iwona Buczyńska, Krzysztof Simon, Anna Piekarska, Jolanta Białkowska-Warzecha, Beata Lorenc, Rafał Krygier, Agnieszka Staniaszek, Jakub Klapaczyński, Jolanta Citko, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Łukasz Laurans, Robert Flisiak. Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience. Hepatitis Monthly 2018; 18(8) doi: 10.5812/hepatmon.80761
|
| 22 |
Hideyuki Tamai, Yoshiyuki Ida, Akira Kawashima, Naoki Shingaki, Ryo Shimizu, Kosaku Moribata, Tetsushi Nasu, Takao Maekita, Mikitaka Iguchi, Jun Kato, Taisei Nakao, Masayuki Kitano. Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus. Gut and Liver 2017; 11(4): 551 doi: 10.5009/gnl16525
|
| 23 |
Jennifer J Kiser. Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?. Clinical Infectious Diseases 2019; 69(10): 1665 doi: 10.1093/cid/ciz025
|